Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Total Voting Rights

20 Mar 2026 16:17

RNS Number : 5452X
Ebiquity PLC
20 March 2026
 

20 March 2026

 

Ebiquity Plc

("the Company" or "Ebiquity")

 

Total Voting Rights

 

The Company notifies that, following the proposed cancellation of 40,749 ordinary shares of 25p ("Ordinary Shares"), its ordinary share capital will consist of 141,215,531 Ordinary Shares. 

 

The proposed cancellation of 40,749 Ordinary Shares follows an amendment ("Amendment") to the terms of the sale and purchase agreement dated 29 March 2022 ("SPA") for the acquisition of the entire issued share capital of Media Management, LLC ("MML"), pursuant to which 679,158 Ordinary Shares (the "Consideration Shares") were issued to the MML Vendors in part payment of the deferred consideration, as announced on 29 July 2025. The Amendment sets a minimum price, being the nominal value of the Company's Ordinary Shares, at which the Consideration Shares may be issued.

 

Pursuant to the Amendment, the number of Consideration Shares to satisfy that portion of the deferred consideration has been re-calculated to be 638,409 Ordinary Shares. As a result, the MML Vendors will transfer back 40,749 Ordinary Shares to the Company for nil consideration and the Ordinary Shares so transferred will be cancelled.

 

The Ebiquity plc Employee Benefit Trust ("EBT") holds 2,262,845 Ordinary Shares to satisfy awards under the Company's share options plans. The trustee of the EBT has agreed not to vote the Ordinary Shares held by it such that these Ordinary Shares are treated as not carrying voting rights.

 

Therefore, following the cancellation of 40,749 Ordinary Shares, the total voting rights in the Company will be 141,215,531. This figure may be used by shareholders as the denominator for calculations to determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Capitalised terms in this announcement shall have the same meaning as in the acquisition announcement on 30 March 2022.

 

Enquiries:

 

Ebiquity plc

Dorcas Murray, Company Secretary

 +44 (0) 20 7650 9600

 

Camarco

Geoffrey Pelham-Lane/ Ben Woodford

ebiquity@camarco.co.uk

Cavendish Capital Markets

Nominated Advisor and Sole Broker

Ben Jeynes/ George Lawson - Corporate Finance

 +44 (0) 20 7220 0500

Julian Morse/ Louise Talbot/ Sunila de Silva - Sales/ ECM

 

 

 

 

About Ebiquity plc

 

Ebiquity is the independent authority in Marketing Effectiveness. Trusted by more than 75 of the top 100 global advertisers - and 500 more worldwide - we analyse over $100 billion in media spend each year. This unmatched scale gives us the deepest data and the sharpest insights in the industry, powering the impartial advice our clients act on to make the right decisions that deliver Effective and Responsible Advertising.

 

Our work is driven by over 650 media experts on the ground in 19 countries. Covering more than 80% of the world's media market, we are the most local and the most global, ensuring local relevance with global consistency.

 

With our evidence-based consultancy, clients transform their media operations, strengthen governance of their investments, and unlock significant incremental business growth.

 

On average, our clients achieve a 15% improvement in ROI and collectively generate over $1 billion in value annually through our digital governance programmes.

For further information, please visit: www.ebiquity.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRURANRNNUOUAR
Date   Source Headline
29th Jul 20243:43 pmRNSIssue of Shares and TVR
16th Jul 20249:49 amRNSIssue of Shares and TVR
8th Jul 20243:11 pmRNSNotification of major holdings
1st Jul 202411:32 amRNSTotal Voting Rights
13th Jun 20241:06 pmRNSTotal Voting Rights
11th Jun 20244:30 pmRNSResults of the AGM
5th Jun 20241:28 pmRNSStandard form for notification of major holdings
28th May 202410:12 amRNSHolding(s) in Company
24th May 202412:13 pmRNSIssue of Shares and TVR
17th May 202411:54 amRNSAnnual Report and notice of AGM
7th May 20247:00 amRNSFinal Results
1st May 20249:00 amRNSNotice of Investor Presentation
26th Apr 20249:18 amRNSNotice of Results
4th Apr 20247:00 amRNSDirectorate Change
20th Mar 20241:53 pmRNSStandard form for notification of major holdings
19th Mar 20244:50 pmRNSStandard form for notification of major holdings
15th Mar 202410:35 amRNSDIRECTORS’ DEALING
12th Mar 20247:00 amRNSTrading Update
11th Mar 20245:49 pmRNSStandard form for notification of major holdings
5th Mar 20248:53 amRNSStandard form for notification of major holdings
20th Nov 20234:42 pmRNSNotification of major holdings
29th Sep 20237:00 amRNSInterim Results
17th Aug 202310:12 amRNSStandard form for notification of major holdings
28th Jul 20239:20 amRNSIssue of Shares and TVR
28th Jun 20234:58 pmRNSBoard composition
5th Jun 202311:28 amRNSIssue of Shares and TVR
24th May 20235:32 pmRNSNotification of major holdings
24th May 20235:29 pmRNSAGM Statement
24th May 20234:14 pmRNSNotification of major holdings
23rd May 20236:00 pmRNSNotification of major holdings
22nd May 20235:55 pmRNSNotification of major holdings
22nd May 20239:44 amRNSIssue of Shares and TVR
19th May 20235:10 pmRNSNotification of major holdings
19th May 20233:22 pmRNSNotification of major holdings
19th May 202312:00 pmRNSNotification of major holdings
15th May 20233:45 pmRNSIssue of Shares and TVR
4th May 20237:00 amRNSNotice of Capital Markets Day
28th Apr 20231:18 pmRNSANNUAL REPORT AND ANNUAL GENERAL MEETING
17th Apr 20237:00 amRNSAppointment of Chief Financial Officer
3rd Apr 20232:06 pmRNSIssue of Shares and TVR
30th Mar 20237:01 amRNSDirectorate Change
30th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
22nd Mar 20233:19 pmRNSNotice of Investor Presentation
22nd Mar 202312:08 pmRNSNotice of Results
20th Feb 202310:23 amRNSIssue of Shares and TVR
7th Feb 20237:00 amRNSTrading Statement
23rd Jan 20235:46 pmRNSIssue of Shares and TVR
6th Jan 20235:18 pmRNSHolding(s) in Company
4th Oct 20225:13 pmRNSIssue of Shares and TVR
30th Sep 20222:16 pmRNSDIRECTORS’ DEALING

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.